A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment

NCT02951117 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No participants enrolled

Conditions

Multiple Myeloma

Interventions

DRUG: Venetoclax
DRUG: ABBV-838
DRUG: Dexamethasone

Sponsor

AbbVie